Amsterdam Neuroscience
-
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
Toorop, A. A., Noteboom, S., Steenwijk, M. D., Gravendeel, J. W., Jasperse, B., Barkhof, F., Strijbis, E. M. M., Rispens, T., Schoonheim, M. M., van Kempen, Z. L. E. & Killestein, J., Feb 2024, In: MULTIPLE SCLEROSIS JOURNAL. 30, 2, p. 266-271 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial
Nauta, I. M., Kessels, R. P. C., Bertens, D., Stam, C. J., Strijbis, E. E. M., Hillebrand, A., Fasotti, L., Uitdehaag, B. M. J., Hulst, H. E., Speckens, A. E. M., Schoonheim, M. M. & de Jong, B. A., 26 Jan 2024, (E-pub ahead of print) In: Journal of neurology.Research output: Contribution to journal › Article › Academic › peer-review
-
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study
Kaçar, S., Coric, D., Ometto, G., Montesano, G., Denniston, A. K., Keane, P. A., Uitdehaag, B. M. J., Crabb, D. P., Schoonheim, M. M., Petzold, A. & Strijbis, E. M. M., 30 Dec 2023, In: Brain sciences. 14, 1Research output: Contribution to journal › Article › Academic › peer-review
- All publications